Search Tag: Abbott

Cardiology Management

Abbott To Take Over St Jude in $25 bln Mega-Cardio Deal

2016 28 Apr

Abbott Laboratories is taking over St. Jude Medical Inc. in a deal worth $25 bln that will create a giant in the cardio-related devices market. The two NYSE-listed companies said in a joint announcement that the combination will “create a premier medical device leader and strengthen Abbott’s long-term growth potential.” They added that the merged... Read more

ICU Management

Abbott to Acquire Alere,Becoming Leader in Point of Care Testing & Advancing Global Diagnostics

2016 18 Feb

ABBOTT GAINS LEADERSHIP IN THE $5.5 BILLION POINT OF CARE SEGMENT, BROADENS DIAGNOSTICS FOOTPRINT AND ENHANCES ACCESS TO FAST-GROWING DIAGNOSTICS CHANNELS- Transaction expected to be immediately accretive to Abbott's ongoing earnings per share upon close- Acquisition will provide access to new product applications, channels and geographies- Alere's... Read more

ICU Management

Rapid Pathogen Testing With PCR/ESI-MS In Practice

2015 31 Dec

Kristoffer Strålin, MD, PhD, is Associate Professor and Senior Consultant at the Department of Infectious Diseases, Karolinska Institute, Stockholm, Sweden. Karolinska Institute is a world renowned medical university, which has the mission of improving people’s health through research and education. Together with Karolinska University Hospital, it is... Read more

ICU Management

Innovation To ID Infection Source Without Blood Culture

2014 16 Sep

A new study suggests a pioneering testing technology could reduce hospital stays by up to eight days and lower annual health care costs for people with serious infections by approximately $2.2 million (€1.5 million / £1.2 million).[1] The cost reductions are based on a health economic model from the RApid Diagnosis of Infections in the CriticAlly IlL... Read more

Executive Health Management

Abbott Tops Industry List for Economic and Social Performance

2014 15 Sep

Abbott, a global healthcare organisation, has been named the second leading company in the pharmaceutical industry by the Dow Jones Sustainability Index (DJSI) for the second consecutive year. This is one of the most prestigious global benchmarks for corporate responsibility and sustainability. Abbott is an industry group leader in healthcare equipment... Read more

ICU Management

Oral Nutritional Supplements in the Hospital Demonstrate Significant Health & Cost Benefits

2013 04 Sep

A recent health economics and outcomes study, conducted by leading health economists and supported by Abbott, found that oral nutritional supplements provided to patients during hospitalization were associated with significant reductions in length of stay and hospitalization cost. Additionally, the 30-day readmission risk was significantly reduced for... Read more

ICU Management

New Data for Abbott’s High Sensitive Troponin Test Shows It May Predict Heart Attack Risk

2013 01 Aug

Abbott announced on July 30, 2013, promising results from a study evaluating its High Sensitive Troponin-I (hsTnI) assay presented at this year’s American Association for Clinical Chemistry (AACC) annual meeting in Houston, Texas. The study, conducted by researchers at Brigham and Women’s Hospital, demonstrated that Abbott’s hsTnI test (currently... Read more

ICU Management

Abbott Previews Next-Generation Blood Screening Prototype during ISBT Meeting in Amsterdam

2013 04 Jun

Abbott previewed a prototype for the company’s next-generation blood screening system at an event coinciding with this year’s International Society of Blood Transfusion (ISBT) Meeting in Amsterdam from June 2-5, 2013. Abbott’s new system features a user-responsive design based upon insights provided by leading blood screening experts from around the... Read more


Endorsed Companies